TerrAscend (TSNDF) Amortization of Deferred Charges (2021 - 2026)

TerrAscend's (TSNDF) quarterly Amortization of Deferred Charges came in at $378000.0 in Q1 2026, down 7.35% year-on-year from $408000.0 in Q1 2025, and down 2.33% on a QoQ basis from $387000.0 in Q4 2025.

TerrAscend (TSNDF) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Amortization of Deferred Charges data on file, last reported at $378000.0 in Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges fell 7.35% year-over-year to $378000.0 in Q1 2026; TTM through Mar 2026 was $1.6 million, a 19.56% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, down 1.36% from the prior year.
  • Amortization of Deferred Charges for Q1 2026 stood at $378000.0, down from $387000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for TSNDF reached as high as $716000.0 in Q1 2024 and fell as low as -$367000.0 in Q4 2023.
  • Historically, Amortization of Deferred Charges has averaged $401941.2 across 5 years, with a median of $439000.0 in 2022.
  • Across the five-year window, Amortization of Deferred Charges tumbled 178.59% in 2023 and surged 550.82% in 2025, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at $467000.0 in 2022, then tumbled by 178.59% to -$367000.0 in 2023, then soared by 223.71% to $454000.0 in 2024, then fell by 14.76% to $387000.0 in 2025, then declined by 2.33% to $378000.0 in 2026.
  • Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $378000.0 in Q1 2026, $387000.0 in Q4 2025, and $403000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.60 Bn 87.73 Bn -
2 Teva Pharmaceutical Industries 35.84 Bn 32.10 Bn 1.97 Bn
3 Zoetis 32.46 Bn 30.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.55 Bn 23.49 Bn 4.39 Bn
5 United Therapeutics 23.12 Bn 20.96 Bn 648.10 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn -
7 Viatris 20.27 Bn 18.47 Bn 1.16 Bn
8 Neurocrine Biosciences 17.78 Bn 16.46 Bn 800.70 Mn
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn
10 TerrAscend 166.39 Mn 165.92 Mn 34.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 378,000.00
Mar 31, 2026 378,000.00
Dec 31, 2025 387,000.00
Dec 31, 2025 387,000.00
Sep 30, 2025 403,000.00
Sep 30, 2025 403,000.00
Jun 30, 2025 397,000.00
Jun 30, 2025 397,000.00
Mar 31, 2025 408,000.00
Mar 31, 2025 408,000.00
Dec 31, 2024 454,000.00
Dec 31, 2024 454,000.00
Sep 30, 2024 386,000.00
Sep 30, 2024 386,000.00
Jun 30, 2024 61,000.00
Jun 30, 2024 61,000.00
Mar 31, 2024 716,000.00
Mar 31, 2024 716,000.00
Dec 31, 2023 -367,000.00
Dec 31, 2023 -367,000.00